In a report released yesterday, Erin Wright from Credit Suisse maintained a Hold rating on Charles River Labs (CRL), with a price target of $110. The company’s shares closed yesterday at $139.12, close to its 52-week high of $139.91.
According to TipRanks.com, Wright is ranked #508 out of 5152 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Charles River Labs with a $140.86 average price target.
See today’s analyst top recommended stocks >>
Charles River Labs’ market cap is currently $6.21B and has a P/E ratio of 50.28. The company has a Price to Book ratio of 5.34.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions.
